For research use only. Not for therapeutic Use.
Tagtociclib Hydrate (Cat No.: I040083) is a potent cyclin-dependent kinase (CDK) inhibitor designed for cancer research and drug discovery. It selectively targets CDK4/6, key regulators of the cell cycle, to induce cell cycle arrest and apoptosis in tumor cells. Its hydrate form enhances solubility and stability, optimizing its effectiveness in in vitro and in vivo studies. Tagtociclib Hydrate is a valuable tool for exploring oncology therapies, particularly in breast cancer and other CDK-driven malignancies, supporting precision medicine and targeted treatment strategies.
CAS Number | 2733575-91-0 |
Synonyms | [(1R,3S)-3-[3-[[5-(methoxymethyl)-2-methylpyrazole-3-carbonyl]amino]-1H-pyrazol-5-yl]cyclopentyl] N-propan-2-ylcarbamate;hydrate |
Molecular Formula | C19H30N6O5 |
Purity | ≥95% |
InChI | InChI=1S/C19H28N6O4.H2O/c1-11(2)20-19(27)29-14-6-5-12(7-14)15-9-17(23-22-15)21-18(26)16-8-13(10-28-4)24-25(16)3;/h8-9,11-12,14H,5-7,10H2,1-4H3,(H,20,27)(H2,21,22,23,26);1H2/t12-,14+;/m0./s1 |
InChIKey | CFGMPDNYFGKCIR-DSHXVJGRSA-N |
SMILES | CC(C)NC(=O)OC1CCC(C1)C2=CC(=NN2)NC(=O)C3=CC(=NN3C)COC.O |
Reference | [1]. Douglas Carl BEHENNA, et al. Cdk2 inhibitors. WO2020157652A2. |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |